Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells.
Luigi LerraAnnafranca FarfallaBeatriz SanzGiuseppe CirilloOrazio VittorioFlorida VoliMarion Le GrandManuela CurcioFiore Pasquale NicolettaAnna DubrovskaSilke HampelFrancesca IemmaGerardo F GoyaPublished in: Pharmaceutics (2018)
With the aim to obtain a site-specific doxorubicin (DOX) delivery in neuroblastoma SH-SY5Y cells, we designed an hybrid nanocarrier combining graphene oxide (GO) and magnetic iron oxide nanoparticles (MNPs), acting as core elements, and a curcumin⁻human serum albumin conjugate as functional coating. The nanohybrid, synthesized by redox reaction between the MNPs@GO system and albumin bioconjugate, consisted of MNPs@GO nanosheets homogeneously coated by the bioconjugate as verified by SEM investigations. Drug release experiments showed a pH-responsive behavior with higher release amounts in acidic (45% at pH 5.0) vs. neutral (28% at pH 7.4) environments. Cell internalization studies proved the presence of nanohybrid inside SH-SY5Y cytoplasm. The improved efficacy obtained in viability assays is given by the synergy of functional coating and MNPs constituting the nanohybrids: while curcumin moieties were able to keep low DOX cytotoxicity levels (at concentrations of 0.44⁻0.88 µM), the presence of MNPs allowed remote actuation on the nanohybrid by a magnetic field, increasing the dose delivered at the target site.
Keyphrases
- reduced graphene oxide
- drug delivery
- induced apoptosis
- drug release
- cell cycle arrest
- magnetic nanoparticles
- cancer therapy
- human serum albumin
- iron oxide nanoparticles
- gold nanoparticles
- endoplasmic reticulum stress
- single cell
- high throughput
- stem cells
- signaling pathway
- cell death
- quantum dots
- cell proliferation
- high resolution
- pi k akt